Replies to post #136798 on PharmaCyte Biotech Inc (PMCB)

[1234jklm]

Your average biotech isn’t trying to treat late stage cancer with encapsulated cells triggering chemotherapy to have maximum impact and minimum side effects.

That’s why we’re investing here.

It’s novel. It’s unique. It’s the future of medical delivery

If we wanted to invest in an ordinary biotech we’d choose another one.

We’ve chosen this one because it’s a game changer.

And that’s what we like about it. Stumbles, delays. Errors and all.

We need to give them a break

They’re attempting something amazing here.

Better than blood travelling at hyper speed even.